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Abstract
Background: Gene duplication is the primary force of new gene evolution. Deciphering whether a pair of duplicated genes
has evolved divergent functions is often challenging. The zebrafish is uniquely positioned to provide insight into the
process of functional gene evolution due to its amenability to genetic and experimental manipulation and because it
possess a large number of duplicated genes.
Methodology/Principal Findings: We report the identification and characterization of two hypoxia-inducible genes in
zebrafish that are co-ortholgs of human IGF binding protein-1 (IGFBP-1). IGFBP-1 is a secreted protein that binds to IGF and
modulates IGF actions in somatic growth, development, and aging. Like their human and mouse counterparts, in adult
zebrafish igfbp-1a and igfbp-1b are exclusively expressed in the liver. During embryogenesis, the two genes are expressed in
overlapping spatial domains but with distinct temporal patterns. While zebrafish IGFBP-1a mRNA was easily detected
throughout embryogenesis, IGFBP-1b mRNA was detectable only in advanced stages. Hypoxia induces igfbp-1a expression
in early embryogenesis, but induces the igfbp-1b expression later in embryogenesis. Both IGFBP-1a and -b are capable of IGF
binding, but IGFBP-1b has much lower affinities for IGF-I and -II because of greater dissociation rates. Overexpression of
IGFBP-1a and -1b in zebrafish embryos caused significant decreases in growth and developmental rates. When tested in
cultured zebrafish embryonic cells, IGFBP-1a and -1b both inhibited IGF-1-induced cell proliferation but the activity of
IGFBP-1b was significantly weaker.
Conclusions/Significance: These results indicate subfunction partitioning of the duplicated IGFBP-1 genes at the levels of
gene expression, physiological regulation, protein structure, and biological actions. The duplicated IGFBP-1 may provide
additional flexibility in fine-tuning IGF signaling activities under hypoxia and other catabolic conditions.
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Introduction
The evolution of gene function is a fundamental issue in modern
biology. Gene duplication is considered to be the primary force of
new gene evolution, and is evident in a number of sequenced
genomes ranging from Bacteria to human [1]. Divergent functions in
duplicates might help permanent preservation of the genes. Two
major hypotheses have been advanced to explain the functional
retention of the duplicated genes. The neofunctionalization hypoth-
esis argues that after duplication one daughter gene retains the
ancestral function while the other acquires new functions [2]. The
duplication-degeneration-complementation (DDC) hypothesis asserts
that the functions of the ancestral gene are partitioned between the
duplicated genes, such that the duplicate genes complement each
other by jointly performing the necessary subfunctions of the
ancestral gene [3]. These two hypotheses may not necessarily be
mutually exclusive. It has been proposed recently that a large portion
of duplicated genes undergo rapid subfunctionalization followed by
prolonged and substantial neofunctionalization [4].
Despite the advance in our understanding of the role of gene
duplication in the evolution of new genes and gene families,
deciphering whether a pair of duplicated genes has evolved
divergent functions is often challenging. The zebrafish is uniquely
positioned to provide insight into the process of functional gene
evolution due to its versatility, amenability to genetic and
experimental manipulation, and because it possess a large number
of duplicated genes. By one estimation, zebrafish has two co-
orthologs for at least 20% of human genes [5]. Recent studies have
suggested that a genome duplication event occurred in the teleost
lineage ,350 million years ago, prior to the beginning of the
teleost radiation [5,6].
We have previously reported the isolation of igfbp-1 (insulin-like
growth factor binding protein-1) that is expressed in the liver in
zebrafish [7] and plays an important role in mediating hypoxia-
induced embryonic growth and developmental delay [8]. Here, we
describe a new and related zebrafish gene. Phylogenetic, gene
structure, and chromosomal location analysis indicate this gene is
an igfbp-1 paralog and therefore we termed it as igfbp-1b and the
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that are related to IGFBP-1 reported in humans and other
mammals. IGFBP-1 is a secreted protein belonging to the IGFBP
gene family [9,10,11]. The IGF signaling pathway is an
evolutionarily conserved pathway that plays important roles in
regulating growth, development, reproduction, and aging [12,13].
IGFBPs selectively bind IGF with high affinities and modulate IGF
interaction with the cell surface IGF-1 receptor (IGF-1R)
[9,10,14]. Like other IGFBPs, IGFBP-1 has conserved N-terminal
and C-terminal domains and a variable linker (L)-domain. Its
expression is highly inducible under a variety of catabolic
conditions such as food deprivation, malnutrition, stress, injury,
and hypoxia [11].
To understand whether the duplicated IGFBP-1 genes have
evolved distinct structural and functional properties, we have
investigated their spatial and temporal expression, physiological
regulation, IGF binding kinetics, and biological activities. These
results indicate that the two IGFBP-1 genes have gone through
subfunction partitioning at the temporal expression, physiological
regulation, protein structure and functional levels and provide
novel insights into the functional conservation and divergence of
the duplicated igfbp-1 genes.
Results
Identification of a new zebrafish IGFBP gene
In searching IGFBP genes in zebrafish, we have identified a new
IGFBP like gene (ENSDARG00000038666, DQ465370) in the
zebrafish genome database. Using 59- and 39-RACE, its full-length
cDNA was determined (DQ465369). The encoded protein
(ABE98257) shares higher identities with IGFBP-1 and -4 than
with other known IGFBPs. Structural analysis suggests that the
mature peptide is composed of 224 aa with a predicted molecular
mass of 23.8 kDa. Like other known IGFBPs, there are 12 cysteine
residues in its N-terminal domain (residues 1–82) and 6 cysteine
residues in its C-terminal domain (residues 156–244; Fig. 1A). A
typical IGFBP motif is present in the N-domain and a
thyroglobulin-1 motif in the C-domain. As shown in Table 1,
the overall sequence identities of this protein with six human
IGFBPs are 35% (IGFBP-1), 28% (IGFBP-2), 28% (IGFBP-3),
33% (IGFBP-4), and 30% (IGFBP-5 and IGFBP-6). Its identities
with the known zebrafish IGFBPs are 50% (IGFBP-1), 28%
(IGFBP-2), 26% (IGFBP-3), and 30% (IGFBP-5), respectively. If
only the N- and C-domains were used for comparison, the
sequence identities were much higher. Among various members of
Figure 1. Structural and phyologenetic analysis. A) Comparison of the new zebrafish IGFBP primary sequence with that of human (h), bovine
(b), chicken (c), and zebrafish (z) IGFBP-1 and -4. Amino acids identical with the new IGFBP are light-shaded. The putative signal sequence of the new
IGFBP is shown in small letters. The IGF-binding motif and thyroglobulin-1 motif conserved among all known IGFBPs are shown in open boxes. The
two cystein residues characteristically located in the L-domain of IGFBP-4 are dark-shaded. B) Phylogenetic tree of the IGFBP gene family. Amino acid
sequences of full-length IGFBPs were analyzed using the Maximum Likelihood method. Values on branches are percentages of times that the two
clades branched as sisters (1000 run). The results indicate that the newly identified IGFBP is most closely related to those in the IGFBP-1 subgroup.
doi:10.1371/journal.pone.0003091.g001
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with IGFBP-1s and IGFBP-4s. IGFBP-4s are unique among the
IGFBP family in that they have two extra cysteine residues in the L-
domain.Nocysteineisfound intheL-domainofthisnewlyidentified
protein (Fig. 1A). In the L-domain of mammalian IGFBP-1, there is
a proline, glutamine, serine, and threonine (PEST) motif, known to
contribute to its susceptibility to proteolysis [15]. The PEST
sequence is present in this protein. Mammalian IGFBP-1 has an
Arg-Gly-Asp (RGD) motif in its C-domain, but it is not found in the
previously reported zebrafish IGFBP-1 [7]. Likewise, this new
IGFBP does not contain any RGD motif (Fig. 1A).
The newly identified gene is a co-ortholog of IGFBP-1
gene
We next performed phylogenetic analysis using full-length
amino acid sequences of all known IGFBPs. In the PlotTest
program, the best model (JTT+G+I) was selected and the tree was
generated using PHYML program. Although the new IGFBP
shares similarly high sequence identities with human IGFBP-1 and
IGFBP-4, phylogenetic analyses grouped it into the IGFBP-1 clade
(Fig. 1B), indicating that it is a paralog or co-ortholog of human
IGFBP-1. We therefore named the previously reported zebrafish
IGFBP-1 gene [7] as igfbp-1a, and this new gene as igfbp-1b.
The genomic structure of igfbp-1b was determined by searching
the zebrafish genome database and genomic PCR analysis. igfbp-1b
is 4,198 bps long and contains 4 exons and 3 introns (Fig. 2A). The
size of igfbp-1b and its overall structure are similar to those of igfbp-
1a [8] (Fig. 2A). We mapped the chromosomal loci of igfbp-1a and
igfbp-1b using the LN54 radiation hybrid panel. While igfbp-1a is
located to linkage group LG 20, igfbp-1b is mapped to LG 2
(Fig. 2B). Further analysis suggested that zebrafish igfbp-1a and five
neighboring genes (LOC563662, ccm2, igfbp-3, LOC562593 and
zp3a) have orthologs locating on human chromosome 7 (Table 2).
The human IGFBP-1 gene resides on chromosome 7 next to the
IGFBP-3 gene in a tail-to-tail fashion [16,17]. Likewise, zebrafish
igfbp-1a and igfbp-3 were found to be next to each other on LG 2,
in a tail-to-tail fashion. In the proximate region, there are five
other zebrafish genes (eng3a, fa04b06d, grb10, inhibal and twhhb),
whose orthologs are located on human chromosome 7. These
results suggest that igfbp-1a and igfbp-1b have syntenic correspon-
dence with the human IGFBP-1 gene.
The duplicated igfbp-1 genes exhibit overlapping and
distinct expression patterns and are regulated by
nutritional state
The spatial and temporal expression patterns of igfbp-1a were
determined and compared to those of igfbp-1b. As shown in Fig. 3A,
while zebrafish IGFBP-1a mRNA was easily detected throughout
embryogenesis, IGFBP-1b mRNA was not detectable until the
prime stage (25 hpf) at low levels. This lasted until 72 hpf. IGFBP-
1b mRNA became easily detectable at 96 hpf larval stage and
thereafter. Whole mounted in situ hybridization analysis results of
IGFBP-1a mRNA expression has been published [7]. In
agreement with the RT-PCR data, whole mounted in situ
hybridization analysis showed that IGFBP-1b mRNA became
detectable at 48 hpf in primordial hepatic tissues (Fig. 3B, panel e)
and the hepatic expression was clearly detected at 72, 96, and
120 hpf (Fig. 3B, panels g, i, k and m). The hybridization signal
was specific because the corresponding sense RNA probe did not
give any positive signals in the same batch of embryos (Fig. 3B,
panels b, d, f, h, j, l, and n).
It has been previously shown that the zebrafish igfbp-1a is
expressed in adult liver in fasted but not well fed animals [7]. We
therefore analyzed the expression of zebrafish IGFBP-1b mRNA
in various adult tissues of normally fed as well as 2-week fasted
animals. As shown in Fig. 3C, IGFBP-1b mRNA was not detected
in fed animals. Two week food deprivation strongly induced the
hepatic IGFBP-1b mRNA expression in both male and female
adult fish. No IGFBP-1b mRNA was detectable in eye, brain, gill,
heart, kidney, gut, ovary, testes and other remaining tissues. Re-
feeding for 1 week reduced IGFBP-1b mRNA to undetectable
levels (Fig. 3C), indicating igfbp-1b is also expressed in adult liver
and its expression is induced by starvation.
To compare the effect of starvation on IGFBP-1a and -1b
mRNA expression, adult zebrafish were deprived of food for up to
3 weeks. As shown in Fig. 3D, the levels of IGFBP-1a and -1b
mRNA in normal, well-fed adult animals were very low. One week
fasting increased the IGFBP-1a and -1b mRNA level by 17,20-
fold (p,0.05). This induction maintained throughout the 3-week
period. Compared to the levels of IGFBP-1a, the IGFBP-1b levels
appeared higher at the end of the third week. Re-feeding of the
fasted fish for 1 week reduced the IGFBP-1a and -1b mRNA levels
to the basal level. No significant change was seen in the levels of b-
actin mRNA (Fig. 3D). These data suggest that igfbp-1a and igfbp-
1b are expressed in overlapping spatial domain(s) during
embryogenesis but they exhibit distinct temporal expression
pattern. In adult stages, both igfbp-1 genes are only expressed in
the liver and their expression levels are regulated by nutritional
status.
The two igfbp-1 genes are differentially regulated by
hypoxia
Hypoxia has been shown to strongly induce zebrafish igfbp-1a
gene expression via activating the HIF-1 pathway during
embryogenesis and in adult stage [7,8]. Sequence analysis of the
2.3 kb region upstream of the translational start site in igfbp-1b
revealed the presence of 5 putative hypoxia response elements
(HREs) and 3 possible HIF-1 ancillary sequences (HAS) (Fig. 4A),
indicating possible involvement of hypoxia/HIF-1 in regulating
Table 1. Sequence identities between the novel zebrafish
IGFBP and other IGFBPs.
Species{/
Protein IGFBP-1 IGFBP-2 IGFBP-3 IGFBP-4 IGFBP-5 IGFBP-6
human 35 28 28 33 30 30
mouse 34 27 30 33 32 27
rat 33 27 28 33 31 27
pig 36 27 30 - 31 -
bovine 37 29 28 33 25 26
chicken 35 27 - 35 - -
frog 33 - - 32* 30 -
salmon 55 - - - - -
trout 55 27 25 24* 31 25
fugu 56*/55*/50* 28*/28* 30 33 30 -
tetraodon 32 30*/29 31/28* - 36* 27
zebrafish 50 28 26 - 30 -
{human (Homo sapiens), mouse (Mus musculus), rat (Rattus norvegicus), pig (Sus
scrofa), bovine (Bos taurus), chicken (Gallus gallus), frog (Xenopus laevis),
salmon (Oncorhynchus tshawytscha), trout (Oncorhynchus mykiss), fugu
(Takifugu rubripes), tetraodon (Tetraodon nigroviridis), zebrafish (Danio rerio).
*Compared with corresponding partial sequences.
doi:10.1371/journal.pone.0003091.t001
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induces igfbp-1b expression, embryos of various stages (0, 24, 48
and 72 hpf) were subjected to hypoxia treatment for 24 h. As
shown in Fig. 4B, 24 h hypoxia treatment of 0, 24, and 48 hpf
embryos resulted in a marked increase in IGFBP-1a mRNA levels.
The effect was not seen in embryos of advanced stage (72–96 hpf).
In contrast, hypoxia had little or only modest effect on the IGFBP-
1b mRNA expression in early embryos (0 and 24 hpf), but it had a
strong effect in later stage (72 and 96 hpf). Further qRT-PCR
analysis indicated that 24 h hypoxia treatment of 0,4 hpf
embryos resulted in a 3.4 fold increase (p,0.01) in IGFBP-1a
mRNA levels, while it caused a 3.7 fold decrease (p,0.001) in
IGFBP-1b mRNA levels (Fig. 4C). Twenty four hour hypoxia
treatment of 24 and 48 hpf embryos resulted in 3.4,5.5 fold,
highly significant increases (p,0.001) in IGFBP-1a mRNA levels
and modest but statistically significant increases in IGFBP-1b
mRNA levels (2.1 and 2.6 fold increases, p,0.01,0.05). A 10.9
fold highly significant (p,0.001) increase was detected in the
IGFBP-1b mRNA levels in 72 hpf, while there was no increase in
the IGFBP-1a mRNA levels at this stage.
Under normoxia and well-fed condition, both IGFBP-1a and -
1b mRNA levels were very low in adult fish, undetectable by RT-
PCR (Fig. 4D). Hypoxia strongly induced the expression of both
genes (Fig. 4D). qRT-PCR analysis results indicated that 24 h
hypoxia treatment resulted in a 10.7 fold increase (p,0.01) in
IGFBP-1a mRNA levels, and a 3.0 fold increase (p,0.01) in
IGFBP-1b mRNA levels (Fig. 4E). Together, these data suggest
that while the expression of both igfbp-1a and igfbp-1b is induced by
hypoxia during embryogenesis and in adult stages, there are clear
differences in the timing and responsiveness of these two genes to
hypoxia. Hypoxia strongly induces the igfbp-1a expression in early
embryogenesis, but it preferentially induces the igfbp-1b expression
later in embryogenesis. In adult stages, hypoxia has a stronger
effect on igfbp-1a than on igfbp-1b.
Figure 2. Genomic structure and chromosomal location of zebrafish igfbp-1a and igfbp-1b. A) A schematic diagram comparing the
genomic structures of igfbp-1a and -1b. Exons are shown as boxes and introns shown as lines. Lightly and darkly shaded areas represent untranslated
region (UTR) and open reading frame (ORF), respectively. The zebrafish igfbp-1a structure is taken from Kajimura et al. (2005). Scale bar is 0.5 kb. B)
Zebrafish igfbp-1a is located on linkage group (LG) 20, 32.16 centiRay (cR) from marker z9209; igfbp-1b is located on LG2, 10.65cR from marker z10764,
respectively. 1cR=148 kb. Scale is 50 cR.
doi:10.1371/journal.pone.0003091.g002
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kinetics
To study the biological actions of the two zebrafish IGFBP-1s,
recombinant IGFBP-1a, -1b, and human IGFBP-1 were produced
in HEK293t cell and purified. The two zebrafish proteins had
different apparent sizes on SDS-PAGE. IGFBP-1a showed as a
doublet and had a greater apparent size (31.7 and 28.7 kDa),
whereas IGFBP-1b was smaller (26.8 kDa; Fig. 5A). Ligand
blotting showed that both IGFBP-1a and -1b proteins are indeed
functional IGF binders (Fig. 5A). The binding kinetics for their
interactions with IGF-I and -II were further analyzed by surface
plasmon resonance (Fig. 5B and Table 3). Human IGFBP-1
showed similar high-affinity binding to IGF-I and -II (KD=5.96
and 8.63 nM). Zebrafish IGFBP-1a binds with very high-affinity to
IGF-I (KD=0.28 nM) and IGF-II (KD=0.34 nM). In both cases, a
very fast association rate (IGF-I, ka=11.8060.04610
5 M
21 s
21;
IGF-II, ka=8.6760.08610
5 M
21 s
21)a n das l o wd i s s o c i a t i o nr a t e
(kd IGF-I, 3.3260.007610
24 s
21;kd IGF-II, 2.9060.007610
24 s
21)
were found, suggesting the existence of highly stable IGFBP-1a/IGF
complexes. The dissociation constants for the interactions between
zebrafish IGFBP-1b and IGF ligands were KD=12.0nM (IGF-I)
and KD=9.33 nM (IGF-II), which are respectively 43 and 27 fold
lower compared with those of zebrafish IGFBP-1a. Interestingly,
IGFBP-1b retains a relatively higher association rate with IGF-I
(ka=1.7160.004610
5 M
21 s
21) and a remarkably higher associa-
tion rate with IGF-II (ka=9.9360.002610
5 M
21 s
21). However,
these complexes were much less stable with very high dissociation
rates (kd IGF-I, 20.6060.0053610
24 s
21; kd IGF-II, 92.606
0.32610
24 s
21). These data suggest that the two zebrafish proteins
have very different IGF binding properties: IGFBP-1b has much
lower affinities to IGFs compared with IGFBP-1a.
IGFBP-1a and -1b have different activity in inhibiting IGF
actions
It has been shown that IGFBP-1a inhibits zebrafish embryo
development by binding to IGFs and sequestering their binding to
the IGF-I receptor [8]. To determine the biological actions of
IGFBP-1b in vivo, capped IGFBP-1b mRNA was co-injected with
GFP mRNA to zebrafish embryos at 1–2 cell stage. Capped
IGFBP-1a mRNA was used as a positive control and GFP mRNA
alone as a negative control. As shown in Fig. 6A, embryos injected
with GFP mRNA alone were indistinguishable in morphology to
those of wild-type embryos. There was no notable difference in
either body length or somite number (Fig. 6A, left panel).
Compared to wild-type or the GFP mRNA group, injection of
IGFBP-1a or -1b mRNA resulted in a significant reduction
(p,0.05) in somite number, suggesting a delay in the develop-
mental rate. The mean body size of IGFBP-1a and -1b mRNA
injected embryos was also significantly smaller than those of wild-
type embryos (p,0.05, Fig. 6A).
To determine and compare the biological activities of zebrafish
IGFBP-1a and -1b in modulating IGF actions, purified IGFBP-1a
or -1b was added to cultured zebrafish embryonic cells (ZF4) in the
presence of absence of IGF-I and BrdU incorporation rates were
measured. Exposure of ZF-4 cells to IGF-I at 20 nM resulted in a
372.8610.2% increase in BrdU labeling index (p,0.05, n=6).
IGFBP-1a, when added together with IGF-1, inhibited IGF-I-
stimulated DNA synthesis in a concentration-dependent manner.
At 10 nM (1:2 molar ration to IGF-I), IGFBP-1a caused a
significant decease in IGF-I action (Fig. 6B). At the highest
concentration (50 nM), IGFBP-1a reduced the DNA synthesis
close to the basal level (148.8611.5% of control), suggesting a near
complete inhibition of IGF-I actions. Consistent with the IGF
binding affinity results, IGFBP-1b had a weaker effect. At 10 nM,
IGFBP-1b caused a 22.7% reduction as compared to the 48.4%
reduction in the case of IGFBP-1a. This difference in their
inhibitory effects is statistically significant (p,0.05). At 20 nM,
IGFBP-1b appeared to have a weaker effect compared to IGFBP-
1a (IGFBP-1a, 184.1610.1% vs. IGFBP-1b, 259.6612.7 of the
control group). These data suggest that both IGFBP-1a and -b are
functional and both inhibit zebrafish embryo growth and
development by binding to IGFs. However, the two proteins are
clearly not identical functionally. IGFBP-1a has a stronger activity
than IGFBP-1b in inhibiting IGF actions.
Discussion
In this study, we have identified a pair of co-orthologs of human
IGFBP-1 in zebrafish and examined their gene structures,
chromosomal locations, spatial and temporal expression patterns,
physiological regulatory mechanisms, ligand binding kinetics, and
biological activities. The conclusion that zebrafish igfbp-1b is a
human IGFBP-1 co-ortholog is well supported by phylogenetic
and detailed structural data. For instance, zebrafish IGFBP-1b has
no cysteine residue in its L-domain, while all known IGFBP-4s
have 2 cysteine residues in the L-domain [18]. It is known that
mammalian IGFBP-4, but not IGFBP-1, is cleaved by a specific
protease, pregnancy associated plasma protease (PAPP)-A, and
that the PAPP-A cleavage site is located in the L-domain of all
known IGFBP-4s [19,20,21,22]. The new IGFBP lacks the basic
residues critical for PAPP-A recognition in the corresponding
region. In many mammalian species, IGFBP-1 and -3 genes are
located next to each other on the same chromosome in a tail-to-tail
orientation. By physical mapping and database searching, we
found that zebrafish igfbp-1a and igfbp-3 are neighboring genes
located on LG20 in a tail-to-tail orientation, resembling the
situation of human IGFBP-1 and -3 genes localized on chromo-
some 7 [16,17]. If zebrafish igfbp-1a and igfbp-1b arose by a
chromosomal duplication event, one would expect that zebrafish
igfbp-1b should also be located next to another igfbp-3 gene. Indeed,
Table 2. Genes located on zebrafish LGs 2 and 20 and those
located on human chromosome 17 and 7.
zebrafish LG.2 human chr. 17 zebrafish LG.20 human chr. 7
AI477439.1 QRICH2
zgc:77429 EIF5A
Dr.104464 LOC342541
igfbp1b IGFBP4
BE201786.1 GFAP
LOC563662 CAMK2B
ccm2 CCM2
igfbp1a IGFBP1
igfbp3 IGFBP3
LOC562593 KBTBD2
zp3a ZP3
eng3a EN2
fa04b06d CAGF28
grb10 GRB10
inhbal INHBA
twhhb SHH
doi:10.1371/journal.pone.0003091.t002
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with significant identity with fish and human IGFBP-3 (data not
shown). Whether these sequences indeed encode a functional
zebrafish igfbp-3 awaits further molecular and functional study. In
addition to these IGFBP genes, we were able to identify a number
of orthologous genes between zebrafish LG2 and human Chr.7.
These synteny relationships strongly suggest that zebrafish igfbp-1a
and igfbp-1b are co-orthologs of the human IGFBP-1 gene and that
they originated from a gene duplication event that occurred prior
to the teleost radiation.
The finding that two igfbp-1 genes are present in the zebrafish
genome raised the interesting question regarding their functional
relationship. After genome duplication, each gene copy can follow
a separate evolutionary fate. It has been postulated that non-
functionalization is the fate for the majority of the duplicate genes
and only 20% or so are retained [23,24]. Indeed, when the
putative zebrafish orthologs of 74 human genes on chromosome
17 were examined, only 15 (20%) were present as duplicate genes
[25,26]. Subfunction partitioning is common among the retained
duplicated genes [5]. Despite a large list of examples, in only a few
cases has the subfunction partitioning of mammalian gene
functions by zebrafish duplicates been explained on a molecular
level [5]. For example, differential temporal and/or spatial
expression profiles have been documented in duplicated zebrafish
hox1a/b and sox9a/b [27,28,29,30]. In those cases, it has been
postulated that the degenerative loss of regulatory modules in each
of the two duplicates may have been sufficient to allow the
preservation of the two genes, such that the duplicates together
retain original functions of the single ancestor gene [5,31]. The
duplicated zebrafish igfbp-1 genes are clear examples of temporal
subfunctioning partitioning. In humans and mouse, IGFBP-1 is
expressed only in the liver [11]. The zebrafish paralogs are also
expressed exclusively in the liver in adult fish. During embryo-
genesis, the two genes are expressed in overlapping spatial
domains. The two genes, however, have distinct temporal
patterns. While zebrafish IGFBP-1a mRNA was easily detected
Figure 3. Temporal and spatial expression patterns of igfbp-1a and igfbp-1b during zebrafish embryogenesis. A) RT-PCR analysis result.
The developmental stages are shown at the top, hpf, hour post fertilization. B) In situ hybridization analysis of IGFBP-1b mRNA. Embryos of 5-somite
(a, b), prim.5 straightening period (c, d), the long bud stage (e, f), 120 hpf hatched embryos (g, h, I, j) and 196 hpf hatched embryos (k, l, m, n) were
analyzed. Shown in panels a, c, e, g, i, k and m are embryos probed with the antisense riboprobe. In panels b, d, f, h, j, l and n, embryos probed with
sense riboprobe are shown. Panels a–f, k and l are lateral views with the head to the left, and panels i, j, m and n are corresponding dorsal views of
panels g, h, k and l, respectively. IGFBP-1b mRNA signals were weakly detectable in the liver at 48 hpf, and highly expressed in the liver of 120 and
196 hpf embryos (indicated by arrowheads). C) Tissue distribution of igfbp-1b mRNA in male and female adult fish. Matured adult male and female
fish were sampled at the beginning of the experiment (Feeding), after fasting for 2 weeks (2 week Fasting) or 2 week fasting followed by 1 week re-
feeding (Refeeding). RNA was extracted from various tissues and subjected to RT-PCR analysis. D) Nutritional regulation of IGFBP-1a and -1b mRNA
levels in adult zebrafish.Total RNA was isolated from adult fish at the beginning of the experiment (Feeding), after fasting for 1 week (1 week Fasting),
2 weeks (2 week Fasting), 3 weeks (3 week Fasting), or refed for a week after a 2 week fasting (Refeeding). RNA was subjected to RT-PCR analysis and
a representative RT-PCR result is shown in the upper panel. The relative levels of IGFBP-1a and -1b mRNA were measured and normalized by
corresponding b-actin signals and shown in the bottom panel. Values are mean6S.E. (n=4). Values marked with different letters (a and b, or A and B)
are significantly different from each other (p,0.05).
doi:10.1371/journal.pone.0003091.g003
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or was present at very low levels in early stages. It is only highly
expressed in advanced embryonic stages.
In humans and mice, IGFBP-1 is highly induced by a variety of
catabolic conditions, including fasting, malnutrition, and endo-
plasmic reticulum stress [11]. Another major physiological cue that
regulates IGFBP-1 expression is hypoxia. Hypoxia triggers the
induction of the human IGFBP-1 gene via the hypoxia-inducible
factor-1 (HIF-1) complex [32]. The results of this study indicate
that fasting and hypoxia induce the hepatic expression of the two
zebrafish IGFBP-1 co-orthologs. One of the interesting findings in
the present study is while both igfbp-1a and igfbp-1b are hypoxia-
inducible, their timing and responsiveness to hypoxia are clearly
different. In early embryonic stages, hypoxia strongly induces the
igfbp-1a expression in early embryogenesis, whereas it represses
igfbp-1b expression. In advanced embryonic stages, it induced a
marked increase in igfbp-1b expression, while the same treatment
had no effect on the levels of igfbp-1a expression. In adult fish,
hypoxia has a stronger effect on igfbp-1a than on igfbp-1b
expression, suggesting that the duplicated genes underwent
subfunction partitioning. We term this type of subfunction
partitioning as inducible or regulation subfunctioning partitioning
as it is distinct from the simply spatial, temporal, qualitative, and
quantitative partitioning previously reported [5].
Figure 4. The expression levels of igfbp-1a and igfbp-1b are differentially regulated by hypoxia. A) Schematic diagram of the 59-flanking
region of igfbp-1b. 2,347 bp before the start codon are shown. 5 hypoxia response elements (HRE: N) and 3 hypoxia inducible factor-1 (HIF-1) ancillary
sequences (HAS: #) are found in this region. B,C) Effects of hypoxia in developing zebrafish embryos. 0, 24, 48, and 72 hpf embryos were subjected
to 24 h hypoxia as described in Materials and Methods. Total RNA was isolated and subjected to RT-PCR and qRT-PCR analysis. Representative RT-PCR
results are shown in the upper panel B). IGFBP-1a and -1b mRNA levels were further analyzed by qRT-PCR and are expressed as relative value to those
of the normoxia groups C). Data shown are means6S.E. of three independent experiments. *p,0.05, **p,0.01 compared to the normoxia group at
the same time point. D, E) Hypoxia increases IGFBP-1a and -1b mRNA levels in adult fish. Total RNA was isolated from individual zebrafish that were
kept in normaxia or intermediate hypoxia for 6 h. Representative RT-PCR results are shown in the upper panel D). qRT-PCR data are expressed as
relative values to those of the normoxia group and shown in the lower panel E). Data shown are means6S.E. of three independent experiments.
*p,0.05, **p,0.01 compared to each group.
doi:10.1371/journal.pone.0003091.g004
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likely due to changes/mutations in their cis-regulatory elements
after the duplication. The HIF-1 complex activates target gene
expression by direct binding to the hypoxia-response element
(HRE; A/G CGTG) [33]. Tazuke et al. (1998) have identified a
HRE located in intron 2 of the human IGFBP-1 gene responsible
for its hypoxia response [32]. We have recently shown that the
induction of zebrafish igfbp-1a expression by hypoxia is mediated
through HIF-1 both in vitro and in vivo [34]. The zebrafish igfbp-1a
promoter contains 13 potential HREs within a 2.1 kb region
upstream of the translational start site and the HRE positioned at
21090/21086 is primarily responsible for the hypoxia and HIF-
1-induced IGFBP-1 expression. An additional cis element, HIF-1
ancillary sequence (HAS), is required for the responsiveness to
hypoxia and to HIF-1 [34]. In this study, we show that there are 5
putative HREs and 3 possible HASs in the 2.3 kb region upstream
of the translational start site of zebrafish igfbp-1b, indicating
possible re-arrangement of these cis elements in the duplicated
gene. This subfunction partitioning of IGFBP-1 genes provides an
excellent opportunity to identify critical regulatory elements.
Further functional studies will undoubtedly reveal the factors
responsible for the unique expression patterns of these two genes.
Subfunction partitioning can involve protein structural changes
and has important functional and evolutionary consequences, but
few such examples have been established in zebrafish. In this
study, we provide biochemical and biological evidence indicating
subfunction partitioning involved protein structural and functional
changes in the duplicated igfbp-1 genes. We show that purified
Figure 5. Zebrafish IGFBP-1a and -1b proteins have different IGF binding affinities and kinetics. A) Purification and characterization of
zebrafish IGFBP-1a and -1b proteins. Isolated IGFBP-1a and -1b proteins were analyzed by SDS-PAGE under non-reducing condition, followed with
Silver staining (S), western blotting (I) and western ligand-blotting (L). 1.0 (S) or 0.3 mg (W and L) purified protein was loaded to each lane. (B) BIAcore
analysis of IGFBP1a and -1b. All binding experiments were carried out at 25uC in HBS buffer with a constant flow rate of 30 mL/min. Different
concentrations of zebrafish IGFBP-1a and -1b or human IGFBP-1 were injected over the surface for 60 seconds followed by a five minute dissociation
period. The sensor surface was regenerated by two 30 second injections of HCl (100 mM). Sensorgram data were analyzed using the BIAcore T100
evaluation Software version 1.1. Concentrations of IGFBP-1a applied were 144 nM, 72 nM, 36 nM, 18 nM and 9 nM, IGFBP-1b were 173 nM, 86.4 nM,
43.2 nM, 21.6 nM and 10.8 nM and human IGFBP-1 were 368 nM, 184 nM, 92 nM, 46 nM and 23 nM.
doi:10.1371/journal.pone.0003091.g005
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molecular mass on SDS-PAGE. A single N-glycosylation motif,
that could account for the larger molecular mass, is found in
IGFBP-1a but not -1b. While both zebrafish IGFBP-1a and -1b
are capable of IGF binding, binding kinetics analysis revealed that
the two proteins have very different IGF binding properties.
Zebrafish IGFBP-1a has very high-affinity for IGF-I
(KD=0.28 nM) and IGF-II (KD=0.34 nM) and the IGFBP-1a/
IGF complexes are highly stable. In comparison, the affinities of
IGFBP-1b to IGF-I and IGF-II are 43 and 27 fold lower.
Interestingly, IGFBP-1b retains a remarkably high association rate
with IGF-I and IGF-II but the IGFBP-1b/IGF complexes are
much less stable, due to the high dissociation rates. In mammalian
IGFBPs, amino acid residues responsible for IGF-binding have
been elucidated [35]. Further mutational analysis of zebrafish
IGFBP-1a and -1b will undoubtedly provide structural insights
underlying the different ligand binding properties of the two
zebrafish IGFBP-1 proteins.
Studies in a variety of species have shown that the IGF signaling
pathway plays a fundamental role in regulating wide range of
physiological events from embryonic development and growth to
life span regulation [12,13]. The multiple forms of IGFBPs bind
the IGF ligands and regulate the availability of the IGFs to the
IGF-1 receptors, therefore providing additional layers of regula-
tion of the IGF signaling. IGFBP-1 is highly inducible under a
variety of catabolic conditions such as food deprivation, malnu-
trition, stress, injury, endoplasmic reticulum stress, and hypoxia
[11]. Recent in vivo studies have indicated that the induced IGFBP-
1 serves as a molecular switch by restricting IGF signaling and
diverts the limited energy resources away from growth and
development toward those metabolic processes essential for
survival [8]. A number of in vitro studies using transgenic mice
have shown that IGFBP-1 has an inhibitory effect on IGF activity
[36,37,38,39,40,41]. The inhibitory effects seem to be mainly
caused by competition for IGF binding with the IGF-1R [11]. In
good agreement with these findings, injection of IGFBP-1a and -
1b mRNA into zebrafish embryos caused significant decreases in
body size and somite number. These overexpression experiments
suggest that IGFBP-1a and -1b are inhibitory proteins and that
they probably act by binding to and inhibiting IGF actions in vivo.
However, the two proteins are clearly not identical in terms of
biological potency. When IGFBP-1a or -1b was added to cultured
zebrafish embryonic cells in the presence of absence of IGF-I,
IGFBP-1b has a significantly lower activity in inhibiting IGF
actions compared to that of IGFBP-1a. This is consistent with the
fact that zebrafish IGFBP-1b has a much lower affinity for IGF-1
and IGF-II.
In conclusion, we have identified and characterized a novel
zebrafish IGFBP gene, igfbp-1b, which is a co-orthologous gene of
human IGFBP-1. The duplicated IGFBP-1 genes have evolved
overlapping yet distinct biological properties through differentially
changing: 1) temporal expression pattern and hypoxia responsive-
ness and timing, 2) protein structure modules that alter their IGF
binding kinetics, and 3) different biological activities (Fig. 7). These
distinct features of the duplicated IGFBP-1 genes could allow
greater flexibility and fine-tuning of IGF actions under various
physiological conditions during development.
Materials and Methods
Chemicals
All chemicals and reagents were purchased from Fisher
Scientific (Pittsburgh, PA) unless noted otherwise. RNase-free
DNase and restriction enzymes were purchased from Promega
(Madison, WI). Taq DNA polymerase and Vent DNA polymerase
were purchased from New England Biolabs (Beverly, MA).
PfuTurbo DNA polymerase were purchased from Stratagene (La
Jolla, CA). Superscript II reverse transcriptase (RT) and
oligonucleotide primers were purchased from Invitrogen Life
Technologies, Inc. (Carlsbad, CA). Oligonucleotide primers for
PCR were purchased from Invitrogen. iQ SYBR Green Supermix
was from Bio-Rad (Hercules, CA).
Animals and experimental procedures
Wild-type zebrafish (Danio rerio) were maintained on a 14 h light
210 h dark cycle at 28 C and fed twice daily. Embryos were
obtained by natural crossing. Fertilized eggs were raised in embryo
medium at 28.5 C and staged according to the standard method
[42]. To prevent pigmentation, embryos were kept in embryo
medium supplemented with 0.003% (w/v) 2-phenylthiourea
beginning at 10 h post fertilization (hpf). In the fasting exper-
iments, adult zebrafish were fasted for 1, 2, or 3 week after 1 week
of acclimation. After 2 week of fasting, the remaining fish were
divided into two groups. The first group continued food
deprivation, while the other group was re-fed for 1 week. In the
hypoxia experiments, oxygen was depleted by bubbling water with
nitrogen gas. Oxygen concentrations were measured using a
dissolved oxygen meter (YSI Model 58, Fisher Scientific,
Table 3. Kinetic analysis of zebrafish IGFBP-1a, -1b and human IGFBP-1 interactions with IGF biosensor surfaces.
IGF-1
ka(610
5 M
216s
21) kd(610
24 s
21) KD(nM) x
2 Relative KD
zebrafish IGFBP-1a 11.8060.040 3.3260.007 0.28 0.2 1.0
zebrafish IGFBP-1b 1.7160.004 20.6060.053 12.0 0.202 42.8
human IGFBP-1 0.5360.001 3.1460.008 5.96 0.032 21.2
IGF-2
ka(610
5 M
216s
21) kd(610
24 s
21) KD(nM) x
2 rekative KD
zebrafish IGFBP-1a 8.6760.08 2.960.007 0.34 3.28 1.0
zebrafish IGFBP-1b 9.9360.002 92.6060.320 9.33 1.26 27.4
human IGFBP-1 0.5360.002 4.5760.009 8.63 0.082 25.5
Association rate (ka), dissociation rate (kd), and dissociation constants (KD: kd/ka) are given.
doi:10.1371/journal.pone.0003091.t003
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group was set as 0.6760.06 mg/l for embryos and
1.8560.16 mg/l for adult fish, whereas the normal ambient
oxygen levels were 6.660.45 mg/l. Fish were exposed to hypoxia
for 24 h (embryo) or 6 h (adult fish) at 28.5 C. All experiments
were conducted in accordance with the guidelines established by
the University Committee on the Use and Care of Animals at the
University of Michigan.
Molecular cloning and physical mapping
Using the human IGFBP-4 amino acid sequence as a query, we
searched the zebrafish genome database (Ensembl Multi Blast
view: http://www.ensembl.org/Multi/blastview?species=Danio_
rerio), and found a putative IGFBP gene (ENSDARG-
00000038666). The full-length sequence of this putative IGFBP
was determined by 59- and 39- rapid amplification of cDNA ends
(RACE) utilizing the SMART RACE kit (Clontech, Mountain
View, CA). Phylogenetic analysis was done using full-length amino
acid sequences by Maximum Likelihood method. In the PlotTest
program, the best model (JTT+G+I) was selected and the tree was
made based on PHYML program. Amino acid sequences used for
this study are summarized in supplemental table (Table S1) with
their accession numbers or reference numbers. Synteny analysis
was carried out using NCBI Map Viewer based on Danio rerio Zv6
Figure 6. Zebrafish IGFBP-1a and IGFBP-1b are both functional but have different activities. A) Expression of IGFBP-1a and -1b reduces
embryo growth and developmental rate in vivo. GFP mRNA (600 pg/embryo), a mixture of IGFBP-1a mRNA (400 pg/embryo) and GFPmRNA (200 pg/
embryo), or IGFBP-1a mRNA (400 pg/embryo) and GFP mRNA (200 pg/embryo) was injected into 1–2 cell stage embryos. The embryos were raised to
24 hpf and body length and somite number were determined. Representative embryos are shown in the left column. Body length and somite
number of each experimental group are shown in the left column. Values are represented as means6S.E. (n=21–29). Groups with common letters
are not significantly different from each other (p,0.05). B) Effects of IGFBP-1a and -1b on IGF-I-stimulated cell proliferation in cultured zebrafish cells.
Serum starved confluent cells were exposed to the media with or without 20 nM IGF-I in the absence or presence of various concentrations of IGFBP-
1s (2, 10, 20 or 50 nM). To evaluate IGF-independent effect, cells are exposed with 50 nM of IGFBP-1s without IGF. The percentage of BrdU-positive
cells in each group was calculated and is shown. Values are means6S.E. (n=3,6). Groups with common letters are not significantly different from
each other (p,0.05).
doi:10.1371/journal.pone.0003091.g006
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view/) and data from zebrafish and human synteny map [43].
Genomic structure was determined by searching the zebrafish
genome (http://www. ensembl.org/Multi/blastview?species Da-
nio rerio) followed by PCR analysis. The LN54 radiation hybrid
panel was used for physical mapping [44].
Reverse transcription (RT)-PCR and quantitative real-time
RT-PCR (qRT-PCR)
Total RNA was isolated from adult zebrafish and embryos. After
DNase treatment, total RNA (500 ng) was reverse-transcribed to
single strand cDNA using SuperScript II reverse transcriptase
according tothe manufacturesinstructions.RT-PCRwasperformed
with a set of primers (59-CTGAGCTTCTCGCGTCTCTGGA-
CGTCATCACAGAG-39 and 59-TCAGTGTGTGAGCTCCTG-
TGGGCA-39) using Taq-DNA polymerase. The signal intensity of
RT-PCR products was measured densitometrically using Image J
software (NIH, Bethesda, MD), and normalized by b-actin levels.
qRT-PCR was carried out on iCycler iQ Multicolor real-time
PCR detection system (Bio-Rad) according to the manufacturer’s
instructions. Primer sequences for real-time qPCR were b-actin:
59-AGGTCATCACCATTGGCAAT-39 and 59-GATGTCGAC-
GTCACACTTCAT-39; IGFBP-1a: 59-CCACCAGTTTCTT-
GCGTATC-39 and 59-AGCCTAACCACAGCCAAAGCGAG-
39; and IGFBP-1b: 59-ACCACCCTACTGAAGAGGACACA-
GA-39 and 59-GCGTTGAGTTGTGACTTGATGCTC-39.
qPCR was performed using iQ SYBR Green Supermix (Bio-
Rad). One ml of cDNA product was used as PCR template.
Plasmid cDNAs for IGFBP-1a, 1b, and b-actin, a housekeeping
gene, were used as controls. Each assay for unknown samples was
performed simultaneously with standard samples and negative
control samples all in triplicate wells in the same plate. Standard
curves constructed from serial dilution of standard plasmids were
analyzed. The number of molecules of a particular gene transcript
was calculated based on the standard curve and normalized to the
b-actin mRNA level. The specificity of the PCR was verified by
denaturing curve analysis and direct sequencing of the products.
Whole mount in situ hybridization
The plasmid containing IGFBP-1b cDNA (746 bps) was
linearized by restriction enzyme digestion, followed by in vitro
transcription reactions with either T7 or T3 RNA polymerase, to
generate digoxigenin (DIG)-labeled RNA probes using an
mMessageMachine kit (Ambion, TX). The specificity of the
riboprobe was verified by dot-blot analysis and it did not cross-
react with full-length IGFBP-1a cDNA. Hybridization was carried
out as described previously [7]. Images were captured with a
Nikon DC50NN camera mounted to a Nikon Eclipse E600
microscope (Melville, NY).
Expression and purification of recombinant IGFBP-1
proteins
Recombinant Myc-tagged and 66Histidine-tagged IGFBP-1a,
IGFBP-1b, and human IGFBP-1 were produced in human
embryonic kidney (HEK) 293t cells. Briefly, cells were cultured
in high glucose Dulbecco’s modified Eagle’s medium supplement-
ed with 10% fetal bovine serum (FBS), 2 mM glutamine, and non-
essential amino acids (Life Technologies). Cells were transfected
with various expression plasmids. The transfected cells were grown
in selection medium containing 1.75 mg/ml Geneticin (G418).
After selection, cloned cells were pooled and maintained in
complete medium containing 0.5 mg/ml G418. Confluent cells
were washed and conditioned in serum-free medium (SFM) for
48 h. The expression of target protein was confirmed by Western
blotting using a monoclonal anti c-myc antibody (Santa Cruz, CA).
Nickel-chelate affinity resin (Ni-NTA agarose, Invitrogen) was
used for affinity purification following manufacturer’s instruction.
Bound protein was eluted with 250 mM imidazol in PBS
containing 2.5 M NaCl and 250 mM NaH2PO4, pH 8.0. To
ensure the absence of IGF-I or -II in the preparation of IGFBP-1s,
affinity-purified material (100 mg) was further loaded onto a
Superdex G-75 column (Amersham), equilibrated, and eluted with
50% formic acid at 0.5 ml/min. At the acidity of the solvent
(pH,1), bound IGF should dissociate from IGFBP and elute
separately [45]. The purified protein was ultrafiltered, dissolved in
water, and lyophilized. After the purity was determined by silver
staining, the purified protein was quantified using a BCA protein
assay kit (Pierce Biotechnology, Rockford, IL). Also, IGF binding
ability was confirmed by western-ligand blot analysis by utilizing
DIG-labeled IGF-1 according to previous study [46]. The
recombinant human IGFBP-1 was purified by affinity chroma-
tography using a metal chelate column (NTA-Sepharose, GE
Healthcare) followed by reversed-phase High Pressure Liquid
Chromatography (RP-HPLC) on a column packed with Nucleosil
Figure 7. A proposed model for the evolution of the paralogous IGFBP-1 genes in zebrafish. The duplicated IGFBP-1 genes have distinct
functions through evolving: 1) differential regulatory mechanisms of gene expression during development, 2) different protein structure and IGF
binding kinetics, and 3) different biological activities. These features of the duplicated IGFBP-1 genes would allow greater flexibility and fine-tuning of
IGF actions under various physiological conditions during development.
doi:10.1371/journal.pone.0003091.g007
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and dissolved in 10 mM HEPES, 150 mM NaCl, 3 mM EDTA,
0.05% TWEEN-20, pH 7.4 (HBS).
Surface plasmon resonance analysis
Surface plasmon resonance experiments were carried out on a
BIAcore T100 instrument (BIAcore AB, Uppsala, Sweden) using
series S CM5 sensor chips and coupling reagents supplied by the
manufacturer. Immobilization of human IGF-I and -II (Diagnostic
Systems Laboratories) was performed by first activating the surface
of the sensor chip with a mixture of EDC/NHS followed by
injection of IGF-I or -II (10 mg/ml in 10 mM sodiumacetate,
pH 4.75). Remaining activated groups were blocked by injection
of 1.0 M ethanolamine. The levels of immobilization were 120
RU and 138 RU for IGF-I and -II, respectively. All binding
experiments were carried out at 25 C in HBS with a constant flow
rate of 30 mL/min. Different concentrations of IGFBP-1s were
injected over the surface for 60 sec followed by a five minute
dissociation period. The sensor surface was regenerated by two
30 sec injections of HCl (100 mM). Sensorgram data were
analyzed using the BIAcore T100 evaluation Software version
1.1. A 1:1 model was globally fitted to the sensorgram data to
obtain ka and kd values for the interaction. The equilibrium
dissociation constant KD was subsequently calculated as the ratio
kd/ka. The reliability of kinetic analysis was shown by lower x-
square value (x
2,5.0).
Microinjection experiment
Capped mRNAs of EGFP, zebrafish IGFBP-1a, and -1b were
synthesized by in vitro using the mMessage mMachine kit (Ambion,
TX). Microinjection volume was estimated at 1 nl/embryo, based
on calibrations using known quantities of solution. EGFP mRNA
(600 pg/embryo) or a mixture of IGFBP mRNA (400 pg/embryo)
and EGFP mRNA (200 pg/embryo) was injected to embryos at 1–
2 cell stage. Body length and somite number were measured at
24 hpf as described previously [8].
Cell culture and BrdU labeling assay
Zebrafish embryonic cells (ZF-4) were plated onto coverslips
placed in 6-well plates and grown to 80–100% confluence. After
20 h serum starvation, cells were exposed to 20 mM 5-bromo-29-
deoxyuridine (BrdU) with or without 20 nM of IGF-I. Various
concentrations of IGFBP-1s (2, 10, 20 or 50 nM) were added
together with IGF-I to examine the effects of IGFBP-1s on IGF
activities. To evaluate possible IGF-independent effect, cells were
treated with 50 nM of IGFBP-1s alone. The percentage of BrdU-
positive cells in each group was determined as reported previously
[47].
Statistics
Statistical significance among experimental groups was deter-
mined by one-way analysis of variance (ANOVA), followed by the
Newman-Keuls multiple comparison test. All values are repre-
sented as means6standard error (S.E.). Calculation was per-
formed using GraphPad Prism 3.0 software (GraphPad Software
Inc., San Diego, CA), and significance was accepted at p,0.05 or
better.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0003091.s001 (0.07 MB
DOC)
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